Dermot Mark Durcan
At a glance: Dermot Mark Durcan is Director at Cencora (COR). Their latest SEC Form 4, filed Jun 22, 2026, reported a purchase of $1.1M. On file: 2 purchase lines ($2.2M) and 0 sale lines ($0).
Disclosed holdings: about $10.9M of COR stock: 31,767 shares reported on their latest Form 4 (filed Jun 22, 2026), valued at the Nov 20, 2026 close of $343.02. This counts only COR shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Cencora, Inc. (COR)
Purchase track record
Strong record. Based on 2 purchases with a full 90 days of price history.
Dermot Mark Durcan's InsiderPrint
5 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Almost only buys, trading about once a year, typically $109K a trade.
- Bump outward: a purchase (5)
- Dent inward: a sale (0)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Jack BoyleDirector · WWW · 100% match
- John SchraudenbachDirector · PAL · 100% match
- William H. Adams IIIDirector · TXO · 100% match
- Robert A. McCabe Jr.Director · NHI · 99% match
- Brian HirschDirector · ACVA · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2024
From the SEC's insider data sets: each open-market buy by Dermot Mark Durcan, matched to how the stock did over the next 90 days against the S&P 500.
2 of 3 buys beat the S&P 500 (67%), median +5.0% vs. the index. Small sample: treat with care. All insider buys: 46%.
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 22SEC | CORCencora, Inc.First buy in 2 yrsPast buys 2/3 beat S&P | Buy | 4,00031,767 held (+14%) | $274.19 | $1.1M | +25.1% |
| May 28SEC | CORCencora, Inc.Past buys 2/3 beat S&P | Buy | 4,00027,767 held (+17%) | $266.26 | $1.1M | +28.8% |
- Buy
Director Dermot Mark Durcan bought $1.1M of COR at $266.26 — first open-market purchase in our records.
Follow Dermot Mark Durcan
Get one email when Dermot Mark Durcan files a new purchase or sale. Free.
At most one email a day about Dermot Mark Durcan, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.